Novo Nordisk Seeks to Expand Liver Disease Treatments in $5.2B Deal for Bay Area Biotech
Novo Nordisk has reshaped countless waistlines. Now the Ozempic maker is aiming a little higher in the abdomen. The Danish...
Novo Nordisk has reshaped countless waistlines. Now the Ozempic maker is aiming a little higher in the abdomen. The Danish...